Oriola, the Finnish healthcare service provider and pharmaceutical wholesaler, and Orifarm, the fast-growing supplier of parallel imported and generic pharmaceuticals, have agreed to continue their long-term partnership. Oriola offers Orifarm pharmaceutical storage and distribution services as well as tailored services in Finland.


Orifarm was founded in 1994 and is a fast-growing supplier of parallel imported and generic pharmaceuticals, providing high quality medicine at a low cost bringing significant savings for both society and consumers. In Finland, Orifarm has operated for 11 years. Nearly 90% of Orifarm's pharmaceuticals are distributed to hospitals, and, in the future, Orifarm intends to strengthen its position with pharmacies too.


- I was a part of the team that established Orifarm's business on the Finnish market and I have worked with Oriola since the beginning. We have been very satisfied with our co-operation with Oriola, and we are happy that it continues. Oriola is a flexible and customer-oriented partner that listens to our needs and keeps a customer perspective in everything it does. Additionally, Oriola has solved our very special needs, explains Orifarm's Managing Director Sanna Raappana.


- I am happy that our smooth co-operation with Orifarm will continue. We want to ensure the high quality and reliable distribution of Orifarm's pharmaceuticals to Finnish consumers, says Kimmo Virtanen, Managing Director of Oriola.


For further information


Oriola Oy
Kimmo Virtanen
Managing Director
tel. +358 (0)10 429 2069
kimmo.virtanen@oriola.fi


Orifarm
Sanna Raappana
Managing Director
tel. +358 (0)50 518 1173
sra@orifarm.com


Oriola - The Channel for Health

Oriola is a Finnish healthcare service provider and pharmaceutical wholesaler. Oriola is part of the Oriola-KD Group. Oriola-KD provides an effective and reliable link between pharmaceutical manufacturers and consumers in Northern Europe. The net sales of the Oriola-KD Group's continuing operations in 2014 were about EUR 1.6 billion. The company currently employs about 2,350 members of staff. Oriola-KD Corporation is listed on the main stock exchange list of NASDAQ OMX Helsinki Oy. For more information, please visit www.oriola.fi/en and www.oriola-kd.com.


Orifarm Group

Orifarm Group is an ambitious operator at the European market for pharmaceuticals. Through their two business areas, parallel import and generic pharmaceuticals, their aim is to create competition and thus great savings for both societies and consumers by providing high quality medicine at low cost. During the past twenty years of existence, Orifarm has become an international company with more than 1,000 employees in seven countries. With a turnover in 2014 of 750 mill. euros, Orifarm is the largest supplier of parallel imported pharmaceuticals in Europe and the aim is to improve this leading position even further in the coming years.

distributed by